Order byBest matchMost fresh

Novavax scores narrower Covid vaccine approval

Digest more
After FDA holdup, Novavax secures full approval for protein-based COVID vaccine
At long last, Novavax has secured a full FDA approval for its protein-based COVID-19 vaccine, though not in the broad population the company had originally sought. | The FDA has approved Novavax’s COVID vaccine in adults ages 65 years and older and in people between the ages of 12 and 64 who have at least one underlying health condition that puts them at high risk for severe COVID outcomes.

Continue reading

Novavax Stock Soars on FDA Approval for New COVID-19 Vaccine
FDA to limit covid shot approval to 65+, those with medical conditions
FDA’s new approach to covid vaccines could have been way worse
Older adults can continue getting covid boosters, but not everyone who wants them can.

Continue reading

FDA panel recommends keeping COVID shots targeted to same strain as last year
FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a public health expert explains the new rules
US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026
Public health experts say that there is no certainty on which strains are going to be dominant.

Continue reading

FDA plans to limit COVID vaccine to only high-risk people. Who would still be eligible?
FDA panel debates COVID vaccine recipe as questions swirl about fall shots
Chicago Tribune24d
FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots
WASHINGTON — The Trump administration’s effort to impose new requirements on Novavax’s COVID ... flu shot, “which has been tried and tested for more than 80 years.” Under federal law ...
MedPage Today24d
FDA Scrutiny of Novavax COVID Shot Sparks Uncertainty About Other Vaccines
The Trump administration's effort to impose new requirements on Novavax's COVID ... to the flu shot, "which has been tried and tested for more than 80 years." Under federal law, the FDA is ...
Inc1mon
Novavax: New COVID-19 Vaccine on Track for FDA Approval
The FDA recently asked Novavax to develop ... update their vaccine recipes to better match the latest COVID-19 variants that are circulating, just like flu shots are updated yearly.
Chicago Tribune29d
Novavax says its COVID-19 shot is on track for full FDA approval after delay
The FDA recently asked Novavax to develop ... update their vaccine recipes to better match the latest COVID-19 variants that are circulating, just like flu shots are updated yearly.
Feedback